NYSE · traded in Congress
Humana HUM
$435.98 +2.24 (+0.52%) Nov 9, 2026 4:24 AM ET
Chart
Analyst ratings
- 16 buy
- 13 hold
- 0 sell
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $41,155M | - | $162M | 0.4% | |
| $40,867M | - | $694M | 1.7% | |
| $39,648M | - | $1,186M | 3.0% | |
| $32,515M | - | $-796M | -2.5% |
New SEC filings
- 8-K 8-K filed Nov 9, 2026
- 144 144 filed Nov 9, 2026
All HUM filings on SEC EDGAR ›
Congress trades in HUM
Members of Congress disclosed 1 transaction in HUM in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 02/10/2026 | Julia Letlow LA05 | Sale | $1,001 - $15,000 | 3/12/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Our coverage
- Humana posts an adjusted loss of 70 cents a share, yet raises its 2026 profit floor to $9.50 Stocks · November 6, 2026
- Humana jumps 14.6% as 95% of its Medicare Advantage members land in 4-star plans for 2027, up from 20% Stocks · October 9, 2026
- UnitedHealthcare, Aetna and Humana shrink 2027 Medicare Advantage choice; Aetna to shed about 950,000 members Stocks · October 1, 2026
- Tesla is no longer priced as a car company: inside the robotaxi and Optimus bet Stocks · September 19, 2026
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.

